Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

SUSMED,Inc. (4263) Price & Analysis

4263 Stock Chart & Stats

¥332.00-¥7.00(-2.06%)
At close: 4:00 PM EDT
JPY 400JPY 500JPY 600JPY 7003 Aug17 Aug31 Aug14 Sep28 Sep13 Oct26 Oct
Day’s Range
JPY 330.00 - JPY 340.00
52-Week Range
JPY 330.00 - JPY 1,231.00
Previous Close
JPY 339.00
Volume
269.90K
Average Volume (3M)
89.20K
Market Cap
JPY 5.63B
Enterprise Value
JPY 10.92B
Total Cash (Recent Filing)
JPY 3.70B
Total Debt (Recent Filing)
JPY 0
Price to Earnings (P/E)
―
Beta
1.02
Next Earnings
Nov 06, 2026
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

Revenue growth of about 81% indicates stronger commercial traction and expanding adoption of the company’s healthcare technology offerings. If sustained, this scale can improve operating leverage, support reinvestment, and create a broader base from which future profitability may develop.

High Gross Margins

Gross margins of approximately 96–98% show that the product and service mix retains substantial value after direct costs. This gives SUSMED meaningful potential to convert future revenue growth into improved earnings once operating expenses are better matched to its expanding revenue base.

Debt-Free Balance Sheet

Zero debt and a sizable equity base reduce solvency pressure and interest obligations while preserving flexibility to fund operations or strategic initiatives. This conservative capitalization provides resilience during continued development, even though persistent losses are consuming part of the equity base.

Bears Say

Persistent Operating Losses

Large operating and net losses show that the current cost structure remains too heavy for the company’s revenue base. Continued losses can delay self-funded growth, weaken capital efficiency, and make the strong top-line performance less durable unless operating leverage improves materially.

Sustained Cash Burn

Negative operating and free cash flow across multiple years means commercial growth is not yet translating into internal cash generation. Ongoing burn can reduce financial resources over time and increase reliance on the company’s equity base to support operations and investment.

Eroding Equity Returns

Negative return on equity and a declining equity base indicate that the company is not yet producing adequate returns on shareholder capital. If this pattern persists, accumulated losses may continue reducing financial capacity and limit the strategic flexibility provided by its debt-free structure.

4263 FAQ

What was SUSMED,Inc.’s price range in the past 12 months?
SUSMED,Inc. lowest stock price was ¥330.00 and its highest was ¥1231.00 in the past 12 months.
What is SUSMED,Inc.’s market cap?
SUSMED,Inc.’s market cap is ¥5.63B.
When is SUSMED,Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were SUSMED,Inc.’s earnings last quarter?
SUSMED,Inc. released its earnings results on Aug 07, 2026. The company reported -¥2.97 earnings per share for the quarter.
Is SUSMED,Inc. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does SUSMED,Inc. pay dividends?
SUSMED,Inc. does not currently pay dividends.
What is SUSMED,Inc.’s EPS estimate?
SUSMED,Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SUSMED,Inc. have?
SUSMED,Inc. has 16,955,300 shares outstanding.
What happened to SUSMED,Inc.’s price movement after its last earnings report?
SUSMED,Inc. reported an EPS of -¥2.97 in its last earnings report. Following the earnings report the stock price went up 0.999%.
Which hedge fund is a major shareholder of SUSMED,Inc.?
Currently, no hedge funds are holding shares in JP:4263
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology